drugset / Trial / NCT03677817

Perioperative Lidocaine Administration in Thoracoscopic Surgery for Improved Postoperative Pain Control

NCT03677817 ↗

Phase 3 Completed 113 enrolled University Hospital, Basel, Switzerland
RandomizedParallel-groupDouble-blindTreatment

Summary

Placebo-controlled study to analyze the effect of perioperative intravenous lidocaine administration on total morphine consumption (TMC) and on pain intensity in thoracoscopic surgery .

Timeline

Start
2019-04-03
Primary completion
2022-08-28
Completion
2022-08-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 3 mg/kg Intravenous

Indications

No indication recorded.